Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics - GreenMedInfo Summary
Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics.
Drug Discov Today. 2020 Jul 25. Epub 2020 Jul 25. PMID: 32721537
Syeda Samira Afrose
Kinases are enzymes that are important for cellular functions, but their overexpression has strong connections with carcinogenesis, rendering them important targets for anticancer drugs. Thymoquinone (TQ) is a natural compound with proven anticancer activities, at least in preclinical studies. TQ can target several kinases, including phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK), Janus kinase/signal transducers and activators of transcription (JAK/STAT), polo-like kinase 1 (PLK1), and tyrosine kinase in different cancer cells and animal models. Inhibiting the activity of kinases or suppressing their expression might be among the mechanisms of TQ anticancer activity. In this review, we discuss the role of TQ in kinase regulation in different cancer models.